USPTO serial 78221814
ALMIRALL
Reviewed by CopyMark Law Group
Reg. 2864969Status 710
- Filing date
- Status date
- Registration date
- Jul 20, 2004
- Examiner
- SMIGA, HOWARD
- Law office
- LAW OFFICE 117
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ALMIRALL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Barcelona, ES
Barcelona, ES
Barcelona, ES
08022 BARCELONA, ES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles T. J. Weigell
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42nd St., 17 Fl.NEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, namely, [ antacids, antiflatulent, ulcer preventive drugs, gastroprokinetic agents; antiplatelet aggregant, antihypersensitives, hypolipaemic agent; antiasthma preparations; antihistamines, antitussive, nasal corticoid, systemic nasal decongestant; antidepressants, ] migraine treatment, peripheral and cerebral vasoregulators; anti-inflammatory, [ topical antiinflammatories; bone metabolism regulating hormone; for the genitourinary system, namely, benign hyperplasia of the prostate, incontinence; analgesics and antipyretics; antibiotics for infectious diseases; haemotology products, namely, recombinant human granulocyte-colony stimulating factor; ] analgesics [ and antipyretics; anti-cellulite preparations; vaginal anti-infectious preparations; topical anti-inflammatory preparations; antiseptic and disinfectant; vitamin B association at high doses; cicatrizant with antibiotic; stimulant laxative mucolytic with anthihistamine; house mark for a line of pharmaceuticals ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific research services; [ namely, scientific, [ technological, and industrial ] research services; ] services pertaining to the analysis of pharmaceutical, medicinal-dietetic, medicinal, [ chemical and veterinary ] products, namely, product development and research services, [ chemical analysis ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Almirall-Prodesfarma, S.A.
- Other trademarks owned by Almirall-Prodesfarma, S.A.
- Other trademarks owned by Almirall-Prodesfarma, S.A.
- Other trademarks owned by ALMIRALL, S.A.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALMIRALL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 4, 2025 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Jul 20, 2023 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jan 8, 2020 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Dec 10, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2017 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED | — |
| Jan 31, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 30, 2014 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jul 30, 2014 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jul 30, 2014 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jul 30, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 15, 2014 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Mar 10, 2011 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Feb 1, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 18, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jan 13, 2010 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jul 20, 2004 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 27, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 7, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 3, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2004 | PAPER RECEIVED | — | |
| Sep 25, 2003 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 19, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 18, 2003 | DOCK | ASSIGNED TO EXAMINER | — |